A retrospective cross-sectional study: fresh cycle endometrial thickness is a sensitive predictor of inadequate endometrial thickness in frozen embryo transfer cycles
© Jimenez et al.; licensee BioMed Central Ltd. 2013
Received: 1 February 2013
Accepted: 6 May 2013
Published: 10 May 2013
The purpose of this study is to assess predictors of inadequate endometrial cavity thickness (ECT), defined as < 8 mm, in frozen embryo transfer (FET) cycles.
This is a retrospective cross-sectional study at an academic fertility center including 274 women who underwent their first endometrial preparation with estradiol for autologous FET in our center from 2001-2009. Multivariable logistic regression was performed to determine predictors of inadequate endometrial development in FET cycles.
Neither age nor duration of estrogen supplementation were associated with FET endometrial thickness. Lower body mass index, nulliparity, previous operative hysteroscopy and thinner fresh cycle endometrial lining were associated with inadequate endometrial thickness in FET cycles. A maximum thickness of 11.5 mm in a fresh cycle was 80% sensitive and 70% specific for inadequate frozen cycle thickness.
Previous fresh cycle endometrial cavity thickness is associated with subsequent FET cycle endometrial cavity thickness. Women with a fresh cycle thickness of 11.5 mm or less may require additional intervention to achieve adequate endometrial thickness in preparation for a frozen cycle.
KeywordsEndometrial thickness Frozen embryo transfer Estrogen supplementation
As in vitro fertilization (IVF) culture techniques continue to improve, the number of embryos transferred in each cycle decreases. Transferring fewer embryos is a key component in preventing multiple gestations and their associated complications. As a result, fresh IVF cycles often lead to supernumerary embryos. Cryopreservation of embryos created during fresh IVF cycles provides a less expensive and time-intensive opportunity for pregnancy. In addition, vitrification has proven to be a superior method for cryopreservation, further improving frozen embryo transfer (FET) pregnancy rates [1, 2]. Therefore, optimization of the FET cycle is crucial.
For FET, the endometrium is frequently artificially prepared with estrogen and progesterone supplementation in order the match the endometrial stage during the critical implantation window . There are a number of protocols used in endometrial preparation . The optimal endometrial thickness is unclear. However, several studies suggest a thickness < 8 mm is associated with implantation failure in both fresh and frozen embryo transfer cycles [5–8]. Given the resources involved in IVF and FET cycles, optimization of an individual’s treatment plan is critical. Women preparing for FET will often require additional estrogen supplementation, or other intervention, if their endometrium is thin. The objective of this study is to determine predictors that may identify women who require additional estrogen supplementation to attain adequate endometrial thickness in preparation for FET cycles to inform future FET cycle planning.
This was a retrospective cross-sectional study. STROBE guidelines for cross-sectional studies were followed . Patients who underwent fresh autologous oocyte retrieval with embryo transfer cycle and a subsequent medicated FET cycle within our center between January 2001 and February 2009 were eligible. Only the first FET cycle in which oral estradiol was used for endometrial preparation was included. Embryos were cryopreserved using a slow freeze protocol. All frozen embryo transfers were performed at the blastocyst stage. Donor oocyte recipients and gestational carriers were excluded. The Institutional Review Board at Washington University School of Medicine approved this study.
Per protocol in our center for blastocyst stage transfers, patients begin oral estradiol 2 mg three times a day on cycle day 1. After at least 12 days of oral estradiol, a serum progesterone and ultrasound is performed to measure endometrial cavity thickness (ECT). If progesterone is < 2.5 ng/ml and endometrial thickness is at least 8 mm, patients begin IM progesterone two days later and embryo transfer is performed after five days of progesterone. If endometrial thickness is < 8 mm, estradiol replacement is continued based on physician preference as oral estradiol 2 mg three times a day or the addition of transdermal estrogen (0.1 mg patches) with re-evaluation after one week.
Medical charts of subjects were reviewed and the following data were collected: age, ethnicity, infertility diagnosis, gravity, parity, body mass index (BMI), dosage and duration of estradiol supplementation, prior uterine surgery, endometrial thickness in the fresh and FET cycle, number of embryos transferred, and pregnancy outcome of the fresh and FET cycle.
Three hundred and six subjects met inclusion criteria. There was incomplete data available on 15 patients and 17 patients had cryopreserved embryos from two fresh cycles transferred during the FET cycle. The remaining 274 subjects were included in the analysis. Standard univariate analyses were performed to determine associations between inadequate endometrial development (defined as < 8 mm) and the following variables: age, duration of estrogen supplementation, BMI, history of prior pregnancy, history of prior operative hysteroscopy and endometrial thickness in fresh embryo transfer cycle. Variables with a p-value <0.05 in the univariate analyses were entered into a logistic regression model assessing their association with inadequate endometrial development. All analyses were performed in the Statistical Package for the Social Science (SPSS) version 16.0 (SPSS Inc., Chicago, IL).
Univariate analysis of variables associated with endometrial thickness in FET cycles
ECTa<8 mm; n=68
ECT ≥8 mm; n=206
BMI b (kg/m 2 )
History of previous pregnancy (%)
History of operative hysteroscopy (%)
Duration of estrogen supplementation (days)
Fresh cycle ECT (mm)
Multivariate analysis of factors predictive of inadequate endometrial thickness in FET cycles
History of previous pregnancy
History of operative hysteroscopy
Fresh cycle ECT d
Our data indicate that lower BMI, nulligravidity, previous uterine surgery, and a thinner endometrial lining during a fresh cycle are associated with inadequate endometrial thickness. In addition, a fresh cycle maximum endometrial thickness of 11.5 mm was found to be a predictor of inadequate endometrial development in a FET cycle indicating that additional estrogen supplementation may be necessary for these cycles. Although the difference we found in fresh cycle endometrial thickness of 10 mm versus 12.9 mm may not represent a clinically significant difference in implantation rate or pregnancy outcome, it may indicate impaired endometrial development.
Bromer et al. also found a positive correlation between endometrial thickness and BMI in patients undergoing clomiphene citrate or FSH treatment . We did not find a significant difference in adequate endometrial development based on age or fertility diagnosis as this group. However, it is possible these patients in our study required additional estrogen during the FET preparation to attain adequate endometrial thickness, and therefore, masking the difference.
When endometrial development is inadequate, it is reasonable to continue estrogen supplementation at the same dose. A potential alternative to unresponsive endometrium is a trial of estradiol via a different route of administration. Because transdermal estradiol does not undergo liver metabolism, there is lower conversion to estrone, and possibly a varied effect on the endometrium . With both interventions, most patients in our study ultimately demonstrated adequate endometrial development and thickness (Figure 1).
Endometrial thickness has long been used as a marker of adequate receptivity of the uterus and as a prognostic factor in embryo transfers. Several studies suggest that pregnancy is less likely when the endometrium is < 8 mm [5–8]. Endometrial thickness < 8 mm does not exclude the possibility of pregnancy, but it is less optimal. In the search for additional markers of success, recent studies have focused on endometrial patterns and sub-endometrial blood flow as a useful adjunct in predicting successful IVF outcomes. A study by Singh et al., looking at endometrial thickness, pattern and sub-endometrial blood flow found a higher pregnancy rate when blood flow to the endometrium was in Zone III (Inner hypoechogenic zone of vascular penetration). They also found that pregnancy rates were highest with an endometrial thickness between 8-10 mm . Chen et al., recently evaluated the combined analysis of endometrial thickness and pattern in predicting outcome of IVF. The author noted that a no triple line endometrial pattern even with a moderate endometrial thickness of 7-14 mm had a detrimental effect on pregnancy outcome, although not the occurrence of pregnancy . They concluded that when a thinner endometrium (< 8 mm) and no triple-line endometrial pattern coexist in an IVF candidate, cryopreservation should be recommended. Despite these findings supporting the importance of endometrial thickness and development, it is important to note that these are surrogate markers of IVF success. Endometrial thickness, in addition to other factors, should be considered.
Several endometrial preparation protocols are utilized, as well as multiple other compounds to attain proper endometrial development. Low-dose aspirin supplementation in women with impaired uterine perfusion may improve uterine blood flow and lead to pregnancy rates similar to women with normal uterine perfusion . Women with uterine fibrosis or thin endometrium for unknown reasons may benefit from prolonged treatment with pentoxifylline and tocopherol [15, 16]. Takasaki et al. showed improvement in endometrial thickness and uterine radial artery resistance after treatment with either vitamin E, I-arginine or sildenafil citrate . Granulocyte colony-stimulating factor (G-CSF) was also recently shown to increase endometrial thickness .
FET is an effective, efficient and affordable means of attaining pregnancy for the patient undergoing IVF. Cryopreservation allows for a decrease in the number of embryos transferred in IVF cycles, while the ability to use preserved embryos in the future leads to an increase in cumulative pregnancy rates. In the patient undergoing FET, predictors of inadequate endometrial development, and potentially inadequate thickness, may help the clinician to be aware and prepared prior to initiation of a new cycle.
Endometrial thickness remains an easily measured and long-employed method of predicting endometrial readiness. In FET cycles in our center, we found that one factor influencing endometrial development is previous endometrial thickness < 11.5 mm. This provides important information for the clinician as these patients may require additional estrogen supplementation. Preparation of the endometrium for FET is the only easily modifiable factor to improve ECT. Other potential factors we identified that can be modified are lower BMI and uterine surgery. Good surgical technique to prevent synechia is critical for adequate endometrial development and should always be practiced. However, in women who have already undergone surgery, this is no longer modifiable. Our data suggests that lower, although normal, BMI is associated with a thinner endometrium. Recommending weight gain would not be appropriate to improve endometrial thickness, and therefore, BMI is not easily modifiable. Our study assists in cycle planning and preparation, and therefore, may decrease prolonged cycles or cancellation and limit costs related to extra visits, ultrasounds and monitoring.
In addition, future study of the employment of ultrasound evaluation of blood flow and pattern would be helpful to determine its utility in making decisions regarding embryo transfer. More research is needed to better understand the mechanism of decreased endometrial thickness as well as how to optimize pregnancy in these patients.
Endometrial thickness during fresh IVF cycles helps to predict endometrial development in future FET cycles. This may help to identify patients who require additional hormonal support for adequate endometrial development.
PTJ is a scholar in the Reproductive Scientist Development Program and a physician in reproductive endocrinology and infertility at the University of Texas Southwestern Medical Center.
SBS is a resident in obstetrics and gynecology at Barnes-Jewish Hospital.
RRO is the division direction of Reproductive Endocrinology and Infertility at Washington University
VSR is the IVF director of the Washington University Reproductive Endocrinology and Infertility clinic
ESJ is a physician in reproductive endocrinology and infertility at Washington University and a Women’s Reproductive Health Research scholar
In vitro fertilization
Frozen embryo transfer
Endometrial cavity thickness
Body mass index
Follicle stimulating hormone
We thank Dr. Susan Lanzendorf and the embryologists at the Washington University IVF Lab and the ultrasonographers at the Washington University REI Clinic.
- Loutradi KE, Kolibianakis EM, Venetis CA, Papanikolaou EG, Pados G, Bontis I, Tarlatzis BC: Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil Steril. 2008, 90: 186-193. 10.1016/j.fertnstert.2007.06.010.View ArticlePubMedGoogle Scholar
- Saito H, Ishida GM, Kaneko T, Kawachiya S, Ohta N, Takahashi T, Saito T, Hiroi M: Application of vitrification to human embryo freezing. Gynecol Obstet Invest. 2000, 49: 145-149. 10.1159/000010236.View ArticlePubMedGoogle Scholar
- Soares SR, Velasco JA, Fernandez M, Bosch E, Remohi J, Pellicer A, Simon C: Clinical factors affecting endometrial receptiveness in oocyte donation cycles. Fertil Steril. 2008, 89: 491-501. 10.1016/j.fertnstert.2008.01.080.View ArticlePubMedGoogle Scholar
- Ghobara T, Vandekerckhove P: Cycle regimens for frozen-thawed embryo transfer. Cochrane Database Syst Rev. 2008, CD003414-Google Scholar
- Abdalla HI, Brooks AA, Johnson MR, Kirkland A, Thomas A, Studd JW: Endometrial thickness: a predictor of implantation in ovum recipients?. Hum Reprod. 1994, 9: 363-365.PubMedGoogle Scholar
- Basir GS, Basir GS, O WS, So WW, Ng EH, Ho PC: Evaluation of cycle-to-cycle variation of endometrial responsiveness using transvaginal sonography in women undergoing assisted reproduction. Ultrasound Obstet Gynecol. 2002, 19: 484-489. 10.1046/j.1469-0705.2002.00685.x.View ArticlePubMedGoogle Scholar
- Dessolle L, Darai E, Cornet D, Rouzier R, Coutant C, Mandelbaum J, Antoine JM: Determinants of pregnancy rate in the donor oocyte model: a multivariate analysis of 450 frozen-thawed embryo transfers. Hum Reprod. 2009, 24: 3082-3089. 10.1093/humrep/dep303.View ArticlePubMedGoogle Scholar
- Gonen Y, Casper RF, Jacobson W, Blankier J: Endometrial thickness and growth during ovarian stimulation: a possible predictor of implantation in in vitro fertilization. Fertil Steril. 1989, 52: 446-450.PubMedGoogle Scholar
- von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370: 1453-1457. 10.1016/S0140-6736(07)61602-X.View ArticlePubMedGoogle Scholar
- Bromer JG, Aldad TS, Taylor HS: Defining the proliferative phase endometrial defect. Fertil Steril. 2009, 91: 698-704. 10.1016/j.fertnstert.2007.12.066.PubMed CentralView ArticlePubMedGoogle Scholar
- Paulson RJ: Hormonal induction of endometrial receptivity. Fertil Steril. 2011, 96: 530-535. 10.1016/j.fertnstert.2011.07.1097.View ArticlePubMedGoogle Scholar
- Singh N, Bahadur A, Mittal S, Malhotra N, Bhatt A: Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hCG by 2D doppler in in-vitro fertilization cycles: a prospective clinical study from a tertiary care unit. J Hum Reprod Sci. 2011, 4: 29-33. 10.4103/0974-1208.82357.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen SL, Wu FR, Luo C, Chen X, Shi XY, Zheng HY, Ni YP: Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study. Reprod Biol Endocrinol. 2010, 8: 30-10.1186/1477-7827-8-30.PubMed CentralView ArticlePubMedGoogle Scholar
- Wada I, Hsu CC, Williams G, Macnamee MC, Brinsden PR: The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Hum Reprod. 1994, 9: 1954-1957.PubMedGoogle Scholar
- Letur-Konirsch H, Guis F, Delanian S: Uterine restoration by radiation sequelae regression with combined pentoxifylline-tocopherol: a phase II study. Fertil Steril. 2002, 77: 1219-1226. 10.1016/S0015-0282(02)03120-5.View ArticlePubMedGoogle Scholar
- Acharya S, Yasmin E, Balen AH: The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies–a report of 20 cases. Hum Fertil (Camb). 2009, 12: 198-203. 10.3109/14647270903377178.View ArticleGoogle Scholar
- Takasaki A, Tamura H, Miwa I, Taketani T, Shimamura K, Sugino N: Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertil Steril. 2010, 93: 1851-1858. 10.1016/j.fertnstert.2008.12.062.View ArticlePubMedGoogle Scholar
- Gleicher N, Vidali A, Barad DH: Successful treatment of unresponsive thin endometrium. Fertil Steril. 2011, 95 (2123): e2113-2127.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.